Skip to main content

Table 2 Outcomes of interest at the end of follow-up (December 31th, 2010) in 1,678 opiate users admitted to a methadone treatment program between 1992-2010

From: Sex-specific disease outcomes of HIV-positive and HIV-negative drug users admitted to an opioid substitution therapy program in Spain: a cohort study

 

Men

Women

p value

 

n = 1,390

n = 298

 

Total follow-up length (p-y)

12,356

2,768

 

Median follow-up (IQR), years

9.1 (3.8-12.8)

9.6 (4.9-13.8)

0.097

Deaths, n (%)

371 (26.7)

70 (24.3)

0.403

Mortality Rate, per 100 p-y (95% CI)

3.0 (2.7-3.3)

2.5 (2.0-3.2)

0.187

Causes of death (n = 425)

  

0.022

HIV/AIDS

134 (37.3)

35 (53.0)

 

Non-natural

104 (29.0)

8 (12.1)

 

Liver

38 (10.6)

8 (12.1)

 

Other

83 (23.1)

15 (22.7)